Tag: MedMen
-
![Cannabis stocks set for a reversal?]()
Cannabis stocks set for a reversal?
I love to look for beat up sectors. From a fundamental perspective, perhaps there are deals out there waiting to be made. From a technical perspective, all markets move in cycles. Nothing moves in an uptrend forever or a downtrend forever. When I find beat up sectors that meet my technical criteria, I get excited.…
-
![iAnthus (IAN.C) shareholders all but wiped out by Gotham Green Partners in recapitalization deal]()
iAnthus (IAN.C) shareholders all but wiped out by Gotham Green Partners in recapitalization deal
For a large part of its early days, one of the main selling points of US multi state cannabis store operator iAnthus (IAN.C) was that it was seemingly run by adults. Unlike their colleagues at MedMen (MMEN.C), which revealed itself as a self-dealing executive wealth generator from day one, iAnthus painted a picture of experience,…
-
MedMen (MMEN.C): The Kings of Cannabis are dead but the stink remains
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote Chris Parry on January 31, 2020.
-
Do not adjust your TV sets – Heritage Cannabis (CANN.C) is a real business
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now. By “nitty-gritty” we mean – numbers. Four weeks ago, Heritage released its Q1, 2020 financials.
-
Aurora (ACB.NYSE) rolls back, Gaia Grow (GAIA.V) rolls on
“The simple fact of the matter is ACB is getting around a THIRD of their product returned in real dollar terms,” wrote Equity Guru’s Chris Parry two months ago, “That means they either REALLY suck at growing weed, or they really sucked at figuring out what the market was going to look like when planning…
-
iAnthus (IAN.C) defaults on debenture payments – but is that a weakness or a tactic?
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay…
-
![MedMen (MMEN.C) CEO Adam Bierman resigns but his pockets continue to fill]()
MedMen (MMEN.C) CEO Adam Bierman resigns but his pockets continue to fill
From the day it landed on the stock market, MedMen (MMEN.C) was a company that drew derision and ire based almost entirely on the decision of its founders to lather themselves in hefty bonuses, hoard most of the voting shares, offer themselves enriching golden parachutes, and put themselves above the shareholders and the long term…
-
This is an actual MedMen (MMEN.C) news release
When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new…
-
2019 weed wrap: The end of the cannabis cycle of cannabis cycles
Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they’re at the predator’s table because they’re the…
-
![Aurora Cannabis (ACB.T): is Cam Battley really worth $280 million?]()
Aurora Cannabis (ACB.T): is Cam Battley really worth $280 million?
On December 23, 2019 Aurora Cannabis (ACB.T) share holders’ painful year (the stock is down 65%) got worse with the announcement that ACB Chief Corporate Officer (CCO), Cam Battley is leaving the company to explore other opportunities. “Cam has been an integral part of the development, growth and expansion of Aurora,” stated Aurora CEO Terry…
